Skip to main content
Quest Diagnostics

Genetic Results in a Cohort of 489 Patients With Inherited Myopathies

ACMG Annual Clinical Genetics Meeting, 2024

American College of Medical Genetics and Genomics

Toronto, Canada, March 12-16, 2024

Poster presentation: Genetic Results in a Cohort of 489 Patients With Inherited Myopathies

Authors: Gall K, Hathaway J, Koskinen L, Alakurtti K, Hagström Å , Segura Castell M, Kuisma H, Seppälä EH, Djupsjöbacka J, Muona M, Pietilä T, Salmenperä P, Saarinen I, Veeraraghavan R, Myllykangas S, Koskenvuo J

Specialty: Genetics

Disclaimer: One or more of the authors of this abstract were employed at the time by BluePrint Genetics, a subsidiary of Quest Diagnostics.

Related content

Publication
X linked myotubular myopathy mimics hereditary spastic paraplegia in two
Conference Presentation
An Automated Quality Control System for the Biochemical Genetics Laboratory
Conference Presentation
Searching beyond exons in nuclear genes: Diagnostic deep intronic and mitochondrial DNA variants in patients with monogenic diabetes
Conference Presentation
Small CNVs, noncoding, and mitochondrial variants are molecularly diagnostic for 4.7% of pediatric patients with inherited retinal disease

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.